Noven Confirms Shire's Withdrawal of European Marketing Application for Daytrana[R].
Business Wire (March 16, 2009)
Permanent Link:
http://vlex.com/vid/noven-confirms-shire-withdrawal-daytrana-60346631
Id. vLex: VLEX-60346631
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Business
Pharmaceutical industry
Business, international
Attention deficit hyperactivity disorder
Transdermal drug delivery systems
Noven Confirms Shire's Withdrawal of European Marketing Application for Daytrana[R].
Noven's 2009 Financial Guidance Unchanged by Application Withdrawal
MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today confirmed that Shir...Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
Other documents:
Uh Weighs Raising Aquarium Fees |
Our Say: Time for Council to Execute Voters' Will On Slots |
Ordinanze Ordinaria n 2494 of Consiglio di Stato, of May 23, 2006
|
16 CFR 1000.1 The Commission.
|
Decisao da Presidencia N 368063 of STF Supremo Tribunal Federal of October 2... |
interdiction onbekwaamverklaring tribunal de premiere instance de bruxelles par jugement prononce le 15 ju... |
resolução n.º 438/2001
|
Armstrong: "Ullrich sube como no lo habia hecho antes" |
acordao n 70024871931 of tribunal de justica do rs decima primeira camara civel of august 27 2008
|
sentenza n 8077 of t.a.r - campania napoli of september 13 2006
|
Acordao N 70026121285 of Tribunal de Justica do RS Decima Terceira Camara Civel of October 30 2008
